Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
The Relapsing-Remitting Multiple Sclerosis (MS) patients research has revealed that the matrix metalloproteinase-2 level in cerebrospinal fluid which is higher then 30 ng/ml during the relapse and/or remission period increases repeated relapse risk during 2 years term by 2.8 times. The rapid MS prog...
Main Authors: | I. V. Smagina, S. A. Yelchaninova, A. V. Popovtseva, Yu. N. Ignatova, A. O. Gridina, A. S. Fedyanin |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2010-08-01
|
Series: | Bûlleten' Sibirskoj Mediciny |
Subjects: | |
Online Access: | https://bulletin.tomsk.ru/jour/article/view/1646 |
Similar Items
-
Multiple sclerosis prevalence and risk factors among the Altai Region population
by: I. V. Smagina, et al.
Published: (2011-04-01) -
Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01) -
Neuritis retrobulbaris of multiple sclerosis patients
by: Yu. N. Ignatova, et al.
Published: (2009-06-01) -
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
by: Stephanie Herman, et al.
Published: (2019-01-01) -
Adhesion molecules and proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients
by: S. A. Yelchaninova, et al.
Published: (2009-02-01)